SCHEMBL5203327

SCHEMBL5203327

N#Cc1cccc(CC(CNC(=O)C2(c3ccccc3)CCCC2)Cc2ccc(Cl)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 9/20 0.51
CYP3A4 P08684 1/20 0.50
CYP2C8 P10632 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
KCNH2 Q12809 1/20 0.50
CNR1 P21554 6/20 0.45
CNR2 P34972 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
ERCC1 P07992 1/20 0.42
ERCC4 Q92889 1/20 0.42
LMNA P02545 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ITGB1 P05556 1/20 0.41
ITGA4 P13612 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204107 0.96 TRPA1 (0.55) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5200626 0.92 TRPA1 (0.51) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5201393 0.92 TRPA1 (0.53) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5203736 0.91 TRPA1 (0.49) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5200442 0.89 TRPA1 (0.46) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5200398 0.89 ALDH1A1 (0.52) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5201553 0.88 TRPA1 (0.46) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5200605 0.87 TRPA1 (0.44) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5202916 0.87 TRPA1 (0.43) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL5203999 0.86 TRPA1 (0.45) TRPA1CYP3A4CYP2C8CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP claimed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP claimed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO claimed